BioVie Inc(NASDAQ:BIVI) 
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. It develops BIV201, which completed Phase 2a clinical trial for the treatment of ascites due to chronic liver cirrhosis. The company was formerly...
Website: http://www.biovieinc.com
Founded: 2013
Full Time Employees: 2
CEO: Terren S. Peizer
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 8.00
H 8.50
L 7.60
C 7.80
V 454,397
10EMA 7.80
20EMA 7.80
60EMA 7.80
120EMA 7.80
250EMA 7.80